| 1 |
Nayir Buyuksahin H, Emiralioglu N, Ademhan Tural D, Ozsezen B, Sunman B, Guzelkas I, Alboğa D, Akgül Erdal M, Yalçın E, Dogru D, Tokatlı A, Ozcelik U, Sivri S, Kiper N. Coexistence of cystic fibrosis with other genetic disorders: A case series. Pediatr Pulmonol 2023;58:345-7. [PMID: 36193028 DOI: 10.1002/ppul.26182] [Reference Citation Analysis]
|
| 2 |
Mauhin W, Brassier A, London J, Subran B, Zeggane A, Besset Q, Jammal C, Montardi C, Mellot C, Strauss C, Borie R, Lidove O. Manifestations pulmonaires des maladies héréditaires du métabolisme. Revue des Maladies Respiratoires 2022. [DOI: 10.1016/j.rmr.2022.09.002] [Reference Citation Analysis]
|
| 3 |
Hashmi SB, Ahmed S. Children with lysinuric protein intolerance: Experience from a lower middle income country. World J Clin Pediatr 2022; 11(4): 369-374 [DOI: 10.5409/wjcp.v11.i4.369] [Reference Citation Analysis]
|
| 4 |
Niinikoski H, Schiff M, Tanner L. Disorders of Amino Acid Transport at the Cell Membrane. Inborn Metabolic Diseases 2022. [DOI: 10.1007/978-3-662-63123-2_25] [Reference Citation Analysis]
|
| 5 |
Goussard P, Pohunek P, Eber E, Midulla F, Di Mattia G, Merven M, Janson JT. Pediatric bronchoscopy: recent advances and clinical challenges. Expert Rev Respir Med 2021;15:453-75. [PMID: 33512252 DOI: 10.1080/17476348.2021.1882854] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 6 |
Broomfield AA, Padidela R, Wilkinson S. Pulmonary Manifestations of Endocrine and Metabolic Diseases in Children. Pediatr Clin North Am 2021;68:81-102. [PMID: 33228944 DOI: 10.1016/j.pcl.2020.09.011] [Reference Citation Analysis]
|
| 7 |
Contreras JL, Ladino MA, Aránguiz K, Mendez GP, Coban-Akdemir Z, Yuan B, Gibbs RA, Burrage LC, Lupski JR, Chinn IK, Vogel TP, Orange JS, Poli MC. Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature. Front Pediatr 2021;9:673957. [PMID: 34095032 DOI: 10.3389/fped.2021.673957] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Hadchouel A, Drummond D, Abou Taam R, Lebourgeois M, Delacourt C, de Blic J. Alveolar proteinosis of genetic origins. Eur Respir Rev 2020;29:190187. [PMID: 33115790 DOI: 10.1183/16000617.0187-2019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Olgac A, Yenicesu I, Ozgul RK, Biberoğlu G, Tümer L. Lysinuric protein intolerance: an overlooked diagnosis. Egypt J Med Hum Genet 2020;21. [DOI: 10.1186/s43042-020-00084-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 10 |
Bush A, Pabary R. Pulmonary alveolarproteinosis in children. Breathe (Sheff) 2020;16:200001. [PMID: 32684993 DOI: 10.1183/20734735.0001-2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 11 |
Yahyaoui R, Pérez-Frías J. Amino Acid Transport Defects in Human Inherited Metabolic Disorders. Int J Mol Sci 2019;21:E119. [PMID: 31878022 DOI: 10.3390/ijms21010119] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 12 |
Broomfield A, Kenth J, Bruce IA, Tan HL, Wilkinson S. Respiratory complications of metabolic disease in the paediatric population: A review of presentation, diagnosis and therapeutic options. Paediatr Respir Rev 2019;32:55-65. [PMID: 31101546 DOI: 10.1016/j.prrv.2019.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 13 |
Bodoy S, Sotillo F, Espino-Guarch M, Sperandeo MP, Ormazabal A, Zorzano A, Sebastio G, Artuch R, Palacín M. Inducible Slc7a7 Knockout Mouse Model Recapitulates Lysinuric Protein Intolerance Disease. Int J Mol Sci 2019;20:E5294. [PMID: 31653080 DOI: 10.3390/ijms20215294] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 14 |
Noguchi A, Takahashi T. Overview of symptoms and treatment for lysinuric protein intolerance. J Hum Genet 2019;64:849-58. [PMID: 31213652 DOI: 10.1038/s10038-019-0620-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 15 |
Cui D, Hu YH, Tang G, Shen D, Chen L, Liao JX, Chen SL. [Clinical features of children with lysinuric protein intolerance and SLC7A7 gene mutation: an analysis of 3 cases]. Zhongguo Dang Dai Er Ke Za Zhi 2019;21:375-80. [PMID: 31014432 DOI: 10.7499/j.issn.1008-8830.2019.04.014] [Reference Citation Analysis]
|
| 16 |
Nogee LM, Trapnell BC. Lung Diseases Associated With Disruption of Pulmonary Surfactant Homeostasis. Kendig's Disorders of the Respiratory Tract in Children 2019. [DOI: 10.1016/b978-0-323-44887-1.00057-2] [Reference Citation Analysis]
|
| 17 |
Gower WA, Birnkrant DJ, Black JB, Nicolai T, Noah TL. Pediatric pulmonology year in review 2017: Part 1. Pediatr Pulmonol 2018;53:1582-6. [PMID: 29790678 DOI: 10.1002/ppul.24036] [Reference Citation Analysis]
|
| 18 |
Toma P, Secinaro A, Sacco O, Curione D, Cutrera R, Ullmann N, Granata C. CT features of diffuse lung disease in infancy. Radiol Med 2018;123:577-85. [PMID: 29569218 DOI: 10.1007/s11547-018-0878-3] [Reference Citation Analysis]
|
| 19 |
Rotoli BM, Barilli A, Visigalli R, Ingoglia F, Milioli M, Di Lascia M, Riccardi B, Puccini P, Dall'Asta V. Downregulation of SLC7A7 Triggers an Inflammatory Phenotype in Human Macrophages and Airway Epithelial Cells. Front Immunol 2018;9:508. [PMID: 29616026 DOI: 10.3389/fimmu.2018.00508] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 20 |
Liszewski MC, Lee EY. Neonatal Lung Disorders: Pattern Recognition Approach to Diagnosis. AJR Am J Roentgenol 2018;210:964-75. [PMID: 29489412 DOI: 10.2214/AJR.17.19231] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 21 |
Eber E, Antón-pacheco JL, de Blic J, Doull I, Faro A, Nenna R, Nicolai T, Pohunek P, Priftis KN, Serio P, Coleman C, Masefield S, Tonia T, Midulla F. ERS statement: interventional bronchoscopy in children. Eur Respir J 2017;50:1700901. [DOI: 10.1183/13993003.00901-2017] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 22 |
Estève E, Krug P, Hummel A, Arnoux JB, Boyer O, Brassier A, de Lonlay P, Vuiblet V, Gobin S, Salomon R, Piètrement C, Bonnefont JP, Servais A, Galmiche L. Renal involvement in lysinuric protein intolerance: contribution of pathology to assessment of heterogeneity of renal lesions. Hum Pathol 2017;62:160-9. [PMID: 28087478 DOI: 10.1016/j.humpath.2016.12.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 23 |
Mauhin W, Habarou F, Gobin S, Servais A, Brassier A, Grisel C, Roda C, Pinto G, Moshous D, Ghalim F, Krug P, Deltour N, Pontoizeau C, Dubois S, Assoun M, Galmiche L, Bonnefont JP, Ottolenghi C, de Blic J, Arnoux JB, de Lonlay P. Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood. Orphanet J Rare Dis 2017;12:3. [PMID: 28057010 DOI: 10.1186/s13023-016-0550-8] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 24 |
Tanner LM, Kurko J, Tringham M, Aho H, Mykkänen J, Näntö-Salonen K, Niinikoski H, Lukkarinen H. Inhaled Sargramostim Induces Resolution of Pulmonary Alveolar Proteinosis in Lysinuric Protein Intolerance. JIMD Rep 2017;34:97-104. [PMID: 27783330 DOI: 10.1007/8904_2016_15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Näntö-salonen K, Schiff M, Niinikoski H. Disorders of Amino Acid Transport at the Cell Membrane. Inborn Metabolic Diseases 2016. [DOI: 10.1007/978-3-662-49771-5_25] [Reference Citation Analysis]
|
